表紙
市場調查報告書
商品編碼
1147450

急性缺血性腦中風治療藥的全球市場 2023-2027

Global Acute Ischemic Stroke Therapeutics Market 2023-2027

出版日期: | 出版商: TechNavio (Infiniti Research Ltd.) | 英文 120 Pages | 訂單完成後即時交付

價格
  • 全貌
  • 簡介
  • 目錄
簡介

急性缺血性腦中風治療藥的市場規模在2023年~2027年間,預測將成長到15億2,449萬美元,在預測期間內預計將以年複合成長率5.72%增長。本報告提供急性缺血性腦中風治療藥市場相關資料,整體分析,市場規模與預測,趨勢,成長促進因素,網羅了課題,再加上約25供應商的供應商分析等資訊。

同時本報告還提供當前全球市場趨勢與推動因素以及整體市場環境的最新分析。

市場成長的主要因素有疾病的盛行率上升,NOACs的採用增加,久坐的生活方式盛行率上升。

目錄

第1章 摘要整理

  • 市場概要

第2章 市場形勢

  • 市場生態系統

第3章 市場規模

  • 市場定義
  • 市場區隔分析
  • 市場規模 2022
  • 市場預測:2022-2027年的預測

第4章 波特的五力分析

  • 五力的摘要
  • 買方議價能力
  • 供給企業談判力
  • 新加入廠商業者的威脅
  • 替代品的威脅
  • 競爭的威脅
  • 市場情況

第5章 各類型的市場區隔

  • 市場明細
  • 各類型比較
  • 血栓溶解藥 - 市場規模與預測 2022-2027
  • 抗凝固劑 - 市場規模與預測 2022-2027
  • 抗血小板劑 - 市場規模與預測 2022-2027
  • 降壓劑 - 市場規模與預測 2022-2027
  • 其他的治療藥 - 市場規模與預測 2022-2027
  • 各類型的市場機會

第6章 各流通管道市場區隔

  • 市場明細
  • 各流通管道比較
  • 醫院藥局 - 市場規模與預測 2022-2027
  • 零售藥局 - 市場規模與預測 2022-2027
  • 線上藥局 - 市場規模與預測 2022-2027
  • 各流通管道的市場機會

第7章 客戶形勢

  • 客戶形勢概要

第8章 各地區形勢

  • 各地區市場區隔
  • 各地區比較
  • 北美 - 市場規模與預測 2022-2027
  • 歐洲 - 市場規模與預測 2022-2027
  • 亞洲 - 市場規模與預測 2022-2027
  • 其他地區(ROW) - 市場規模與預測 2022-2027
  • 美國 - 市場規模與預測 2022-2027
  • 英國 - 市場規模與預測 2022-2027
  • 德國 - 市場規模與預測 2022-2027
  • 中國 - 市場規模與預測 2022-2027
  • 加拿大 - 市場規模與預測 2022-2027
  • 各地區形勢的市場機會

第9章 促進因素,課題,及趨勢

  • 推動市場要素
  • 市場課題
  • 推動因素與課題的影響
  • 市場趨勢

第10章 業者情勢

  • 概要
  • 業者情勢
  • 混亂狀況
  • 產業的風險

第11章 供應商分析

  • 交易廠商
  • 供應商的市場定位
  • Amgen Inc.
  • AstraZeneca Plc
  • Athersys Inc.
  • Bayer AG
  • Biogen Inc.
  • Boehringer Ingelheim International GmbH
  • Bristol Myers Squibb Co.
  • Daiichi Sankyo Co. Ltd.
  • F. Hoffmann La Roche Ltd.
  • Johnson and Johnson
  • Medtronic Plc
  • Merck and Co. Inc.
  • Pfizer Inc.
  • Sanofi SA
  • Teva Pharmaceutical Industries Ltd.

第12章 附錄

目錄
Product Code: IRTNTR45749

Technavio has been monitoring the acute ischemic stroke therapeutics market and it is poised to grow by $1524.49 mn during 2023-2027, accelerating at a CAGR of 5.72% during the forecast period. Our report on the acute ischemic stroke therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of disease, increasing adoption of NOACs, and increasing prevalence of sedentary lifestyles.

Technavio's acute ischemic stroke therapeutics market is segmented as below:

By Type

  • Thrombolytics
  • Anticoagulants
  • Antiplatelets
  • Antihypertensives

By Distribution Channel

  • Hospital pharmacies
  • Retail pharmacies
  • Online pharmacies

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the TBI, a value-addition in AIS research as one of the prime reasons driving the acute ischemic stroke therapeutics market growth during the next few years. Also, the advent of genomic medicine and a strong pipeline will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the acute ischemic stroke therapeutics market covers the following areas:

  • Acute ischemic stroke therapeutics market sizing
  • Acute ischemic stroke therapeutics market forecast
  • Acute ischemic stroke therapeutics market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading acute ischemic stroke therapeutics market vendors that include Athersys Inc., Bayer AG, Biogen Inc., Boehringer Ingelheim International GmbH, Medtronic Plc, NoNO Inc., SanBio Co Ltd., Stryker Corp., Amgen Inc., AstraZeneca Plc, Bristol Myers Squibb Co., Daiichi Sankyo Co. Ltd., F. Hoffmann La Roche Ltd., Johnson and Johnson, Merck and Co. Inc., Pfizer Inc., Sanofi SA, and Teva Pharmaceutical Industries Ltd. Also, the acute ischemic stroke therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
  • Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel
  • Exhibit 07: Executive Summary - Chart on Incremental Growth
  • Exhibit 08: Executive Summary - Data Table on Incremental Growth
  • Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
  • Exhibit 10: Parent market
  • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
  • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
  • Exhibit 13: Market segments
  • 3.3 Market size 2022
  • 3.4 Market outlook: Forecast for 2022-2027
  • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Five Forces Analysis

  • 4.1 Five forces summary
  • Exhibit 18: Five forces analysis - Comparison between 2022 and 2027
  • 4.2 Bargaining power of buyers
  • Exhibit 19: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
  • 4.3 Bargaining power of suppliers
  • Exhibit 20: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
  • 4.4 Threat of new entrants
  • Exhibit 21: Threat of new entrants - Impact of key factors in 2022 and 2027
  • 4.5 Threat of substitutes
  • Exhibit 22: Threat of substitutes - Impact of key factors in 2022 and 2027
  • 4.6 Threat of rivalry
  • Exhibit 23: Threat of rivalry - Impact of key factors in 2022 and 2027
  • 4.7 Market condition
  • Exhibit 24: Chart on Market condition - Five forces 2022 and 2027

5 Market Segmentation by Type

  • 5.1 Market segments
  • Exhibit 25: Chart on Type - Market share 2022-2027 (%)
  • Exhibit 26: Data Table on Type - Market share 2022-2027 (%)
  • 5.2 Comparison by Type
  • Exhibit 27: Chart on Comparison by Type
  • Exhibit 28: Data Table on Comparison by Type
  • 5.3 Thrombolytics - Market size and forecast 2022-2027
  • Exhibit 29: Chart on Thrombolytics - Market size and forecast 2022-2027 ($ million)
  • Exhibit 30: Data Table on Thrombolytics - Market size and forecast 2022-2027 ($ million)
  • Exhibit 31: Chart on Thrombolytics - Year-over-year growth 2022-2027 (%)
  • Exhibit 32: Data Table on Thrombolytics - Year-over-year growth 2022-2027 (%)
  • 5.4 Anticoagulants - Market size and forecast 2022-2027
  • Exhibit 33: Chart on Anticoagulants - Market size and forecast 2022-2027 ($ million)
  • Exhibit 34: Data Table on Anticoagulants - Market size and forecast 2022-2027 ($ million)
  • Exhibit 35: Chart on Anticoagulants - Year-over-year growth 2022-2027 (%)
  • Exhibit 36: Data Table on Anticoagulants - Year-over-year growth 2022-2027 (%)
  • 5.5 Antiplatelets - Market size and forecast 2022-2027
  • Exhibit 37: Chart on Antiplatelets - Market size and forecast 2022-2027 ($ million)
  • Exhibit 38: Data Table on Antiplatelets - Market size and forecast 2022-2027 ($ million)
  • Exhibit 39: Chart on Antiplatelets - Year-over-year growth 2022-2027 (%)
  • Exhibit 40: Data Table on Antiplatelets - Year-over-year growth 2022-2027 (%)
  • 5.6 Antihypertensives - Market size and forecast 2022-2027
  • Exhibit 41: Chart on Antihypertensives - Market size and forecast 2022-2027 ($ million)
  • Exhibit 42: Data Table on Antihypertensives - Market size and forecast 2022-2027 ($ million)
  • Exhibit 43: Chart on Antihypertensives - Year-over-year growth 2022-2027 (%)
  • Exhibit 44: Data Table on Antihypertensives - Year-over-year growth 2022-2027 (%)
  • 5.7 Other therapeutics - Market size and forecast 2022-2027
  • Exhibit 45: Chart on Other therapeutics - Market size and forecast 2022-2027 ($ million)
  • Exhibit 46: Data Table on Other therapeutics - Market size and forecast 2022-2027 ($ million)
  • Exhibit 47: Chart on Other therapeutics - Year-over-year growth 2022-2027 (%)
  • Exhibit 48: Data Table on Other therapeutics - Year-over-year growth 2022-2027 (%)
  • 5.8 Market opportunity by Type
  • Exhibit 49: Market opportunity by Type ($ million)

6 Market Segmentation by Distribution Channel

  • 6.1 Market segments
  • Exhibit 50: Chart on Distribution Channel - Market share 2022-2027 (%)
  • Exhibit 51: Data Table on Distribution Channel - Market share 2022-2027 (%)
  • 6.2 Comparison by Distribution Channel
  • Exhibit 52: Chart on Comparison by Distribution Channel
  • Exhibit 53: Data Table on Comparison by Distribution Channel
  • 6.3 Hospital pharmacies - Market size and forecast 2022-2027
  • Exhibit 54: Chart on Hospital pharmacies - Market size and forecast 2022-2027 ($ million)
  • Exhibit 55: Data Table on Hospital pharmacies - Market size and forecast 2022-2027 ($ million)
  • Exhibit 56: Chart on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
  • Exhibit 57: Data Table on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
  • 6.4 Retail pharmacies - Market size and forecast 2022-2027
  • Exhibit 58: Chart on Retail pharmacies - Market size and forecast 2022-2027 ($ million)
  • Exhibit 59: Data Table on Retail pharmacies - Market size and forecast 2022-2027 ($ million)
  • Exhibit 60: Chart on Retail pharmacies - Year-over-year growth 2022-2027 (%)
  • Exhibit 61: Data Table on Retail pharmacies - Year-over-year growth 2022-2027 (%)
  • 6.5 Online pharmacies - Market size and forecast 2022-2027
  • Exhibit 62: Chart on Online pharmacies - Market size and forecast 2022-2027 ($ million)
  • Exhibit 63: Data Table on Online pharmacies - Market size and forecast 2022-2027 ($ million)
  • Exhibit 64: Chart on Online pharmacies - Year-over-year growth 2022-2027 (%)
  • Exhibit 65: Data Table on Online pharmacies - Year-over-year growth 2022-2027 (%)
  • 6.6 Market opportunity by Distribution Channel
  • Exhibit 66: Market opportunity by Distribution Channel ($ million)

7 Customer Landscape

  • 7.1 Customer landscape overview
  • Exhibit 67: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

8 Geographic Landscape

  • 8.1 Geographic segmentation
  • Exhibit 68: Chart on Market share By Geographical Landscape 2022-2027 (%)
  • Exhibit 69: Data Table on Market share By Geographical Landscape 2022-2027 (%)
  • 8.2 Geographic comparison
  • Exhibit 70: Chart on Geographic comparison
  • Exhibit 71: Data Table on Geographic comparison
  • 8.3 North America - Market size and forecast 2022-2027
  • Exhibit 72: Chart on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibit 73: Data Table on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibit 74: Chart on North America - Year-over-year growth 2022-2027 (%)
  • Exhibit 75: Data Table on North America - Year-over-year growth 2022-2027 (%)
  • 8.4 Europe - Market size and forecast 2022-2027
  • Exhibit 76: Chart on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibit 77: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibit 78: Chart on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibit 79: Data Table on Europe - Year-over-year growth 2022-2027 (%)
  • 8.5 Asia - Market size and forecast 2022-2027
  • Exhibit 80: Chart on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibit 81: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibit 82: Chart on Asia - Year-over-year growth 2022-2027 (%)
  • Exhibit 83: Data Table on Asia - Year-over-year growth 2022-2027 (%)
  • 8.6 Rest of World (ROW) - Market size and forecast 2022-2027
  • Exhibit 84: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibit 85: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibit 86: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • Exhibit 87: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • 8.7 US - Market size and forecast 2022-2027
  • Exhibit 88: Chart on US - Market size and forecast 2022-2027 ($ million)
  • Exhibit 89: Data Table on US - Market size and forecast 2022-2027 ($ million)
  • Exhibit 90: Chart on US - Year-over-year growth 2022-2027 (%)
  • Exhibit 91: Data Table on US - Year-over-year growth 2022-2027 (%)
  • 8.8 UK - Market size and forecast 2022-2027
  • Exhibit 92: Chart on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibit 93: Data Table on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibit 94: Chart on UK - Year-over-year growth 2022-2027 (%)
  • Exhibit 95: Data Table on UK - Year-over-year growth 2022-2027 (%)
  • 8.9 Germany - Market size and forecast 2022-2027
  • Exhibit 96: Chart on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibit 97: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibit 98: Chart on Germany - Year-over-year growth 2022-2027 (%)
  • Exhibit 99: Data Table on Germany - Year-over-year growth 2022-2027 (%)
  • 8.10 China - Market size and forecast 2022-2027
  • Exhibit 100: Chart on China - Market size and forecast 2022-2027 ($ million)
  • Exhibit 101: Data Table on China - Market size and forecast 2022-2027 ($ million)
  • Exhibit 102: Chart on China - Year-over-year growth 2022-2027 (%)
  • Exhibit 103: Data Table on China - Year-over-year growth 2022-2027 (%)
  • 8.11 Canada - Market size and forecast 2022-2027
  • Exhibit 104: Chart on Canada - Market size and forecast 2022-2027 ($ million)
  • Exhibit 105: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
  • Exhibit 106: Chart on Canada - Year-over-year growth 2022-2027 (%)
  • Exhibit 107: Data Table on Canada - Year-over-year growth 2022-2027 (%)
  • 8.12 Market opportunity By Geographical Landscape
  • Exhibit 108: Market opportunity By Geographical Landscape ($ million)

9 Drivers, Challenges, and Trends

  • 9.1 Market drivers
  • 9.2 Market challenges
  • 9.3 Impact of drivers and challenges
  • Exhibit 109: Impact of drivers and challenges in 2022 and 2027
  • 9.4 Market trends

10 Vendor Landscape

  • 10.1 Overview
  • 10.2 Vendor landscape
  • Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
  • 10.3 Landscape disruption
  • Exhibit 111: Overview on factors of disruption
  • 10.4 Industry risks
  • Exhibit 112: Impact of key risks on business

11 Vendor Analysis

  • 11.1 Vendors covered
  • Exhibit 113: Vendors covered
  • 11.2 Market positioning of vendors
  • Exhibit 114: Matrix on vendor position and classification
  • 11.3 Amgen Inc.
  • Exhibit 115: Amgen Inc. - Overview
  • Exhibit 116: Amgen Inc. - Product / Service
  • Exhibit 117: Amgen Inc. - Key offerings
  • 11.4 AstraZeneca Plc
  • Exhibit 118: AstraZeneca Plc - Overview
  • Exhibit 119: AstraZeneca Plc - Product / Service
  • Exhibit 120: AstraZeneca Plc - Key news
  • Exhibit 121: AstraZeneca Plc - Key offerings
  • 11.5 Athersys Inc.
  • Exhibit 122: Athersys Inc. - Overview
  • Exhibit 123: Athersys Inc. - Product / Service
  • Exhibit 124: Athersys Inc. - Key offerings
  • 11.6 Bayer AG
  • Exhibit 125: Bayer AG - Overview
  • Exhibit 126: Bayer AG - Business segments
  • Exhibit 127: Bayer AG - Key offerings
  • Exhibit 128: Bayer AG - Segment focus
  • 11.7 Biogen Inc.
  • Exhibit 129: Biogen Inc. - Overview
  • Exhibit 130: Biogen Inc. - Product / Service
  • Exhibit 131: Biogen Inc. - Key offerings
  • 11.8 Boehringer Ingelheim International GmbH
  • Exhibit 132: Boehringer Ingelheim International GmbH - Overview
  • Exhibit 133: Boehringer Ingelheim International GmbH - Business segments
  • Exhibit 134: Boehringer Ingelheim International GmbH - Key news
  • Exhibit 135: Boehringer Ingelheim International GmbH - Key offerings
  • Exhibit 136: Boehringer Ingelheim International GmbH - Segment focus
  • 11.9 Bristol Myers Squibb Co.
  • Exhibit 137: Bristol Myers Squibb Co. - Overview
  • Exhibit 138: Bristol Myers Squibb Co. - Product / Service
  • Exhibit 139: Bristol Myers Squibb Co. - Key offerings
  • 11.10 Daiichi Sankyo Co. Ltd.
  • Exhibit 140: Daiichi Sankyo Co. Ltd. - Overview
  • Exhibit 141: Daiichi Sankyo Co. Ltd. - Business segments
  • Exhibit 142: Daiichi Sankyo Co. Ltd. - Key news
  • Exhibit 143: Daiichi Sankyo Co. Ltd. - Key offerings
  • Exhibit 144: Daiichi Sankyo Co. Ltd. - Segment focus
  • 11.11 F. Hoffmann La Roche Ltd.
  • Exhibit 145: F. Hoffmann La Roche Ltd. - Overview
  • Exhibit 146: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibit 147: F. Hoffmann La Roche Ltd. - Key news
  • Exhibit 148: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibit 149: F. Hoffmann La Roche Ltd. - Segment focus
  • 11.12 Johnson and Johnson
  • Exhibit 150: Johnson and Johnson - Overview
  • Exhibit 151: Johnson and Johnson - Business segments
  • Exhibit 152: Johnson and Johnson - Key news
  • Exhibit 153: Johnson and Johnson - Key offerings
  • Exhibit 154: Johnson and Johnson - Segment focus
  • 11.13 Medtronic Plc
  • Exhibit 155: Medtronic Plc - Overview
  • Exhibit 156: Medtronic Plc - Business segments
  • Exhibit 157: Medtronic Plc - Key news
  • Exhibit 158: Medtronic Plc - Key offerings
  • Exhibit 159: Medtronic Plc - Segment focus
  • 11.14 Merck and Co. Inc.
  • Exhibit 160: Merck and Co. Inc. - Overview
  • Exhibit 161: Merck and Co. Inc. - Business segments
  • Exhibit 162: Merck and Co. Inc. - Key news
  • Exhibit 163: Merck and Co. Inc. - Key offerings
  • Exhibit 164: Merck and Co. Inc. - Segment focus
  • 11.15 Pfizer Inc.
  • Exhibit 165: Pfizer Inc. - Overview
  • Exhibit 166: Pfizer Inc. - Product / Service
  • Exhibit 167: Pfizer Inc. - Key news
  • Exhibit 168: Pfizer Inc. - Key offerings
  • 11.16 Sanofi SA
  • Exhibit 169: Sanofi SA - Overview
  • Exhibit 170: Sanofi SA - Business segments
  • Exhibit 171: Sanofi SA - Key news
  • Exhibit 172: Sanofi SA - Key offerings
  • Exhibit 173: Sanofi SA - Segment focus
  • 11.17 Teva Pharmaceutical Industries Ltd.
  • Exhibit 174: Teva Pharmaceutical Industries Ltd. - Overview
  • Exhibit 175: Teva Pharmaceutical Industries Ltd. - Business segments
  • Exhibit 176: Teva Pharmaceutical Industries Ltd. - Key news
  • Exhibit 177: Teva Pharmaceutical Industries Ltd. - Key offerings
  • Exhibit 178: Teva Pharmaceutical Industries Ltd. - Segment focus

12 Appendix

  • 12.1 Scope of the report
  • 12.2 Inclusions and exclusions checklist
  • Exhibit 179: Inclusions checklist
  • Exhibit 180: Exclusions checklist
  • 12.3 Currency conversion rates for US$
  • Exhibit 181: Currency conversion rates for US$
  • 12.4 Research methodology
  • Exhibit 182: Research methodology
  • Exhibit 183: Validation techniques employed for market sizing
  • Exhibit 184: Information sources
  • 12.5 List of abbreviations
  • Exhibit 185: List of abbreviations

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Type
  • Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel
  • Exhibits7: Executive Summary - Chart on Incremental Growth
  • Exhibits8: Executive Summary - Data Table on Incremental Growth
  • Exhibits9: Executive Summary - Chart on Vendor Market Positioning
  • Exhibits10: Parent market
  • Exhibits11: Market Characteristics
  • Exhibits12: Offerings of vendors included in the market definition
  • Exhibits13: Market segments
  • Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibits18: Historic Market Size - Data Table on global acute ischemic stroke therapeutics market 2017 - 2021 ($ million)
  • Exhibits19: Historic Market Size - Type Segment 2017 - 2021 ($ million)
  • Exhibits20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
  • Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
  • Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
  • Exhibits23: Five forces analysis - Comparison between2022 and 2027
  • Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
  • Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
  • Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
  • Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
  • Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
  • Exhibits29: Chart on Market condition - Five forces 2022 and 2027
  • Exhibits30: Chart on Type - Market share 2022-2027 (%)
  • Exhibits31: Data Table on Type - Market share 2022-2027 (%)
  • Exhibits32: Chart on Comparison by Type
  • Exhibits33: Data Table on Comparison by Type
  • Exhibits34: Chart on Thrombolytics - Market size and forecast 2022-2027 ($ million)
  • Exhibits35: Data Table on Thrombolytics - Market size and forecast 2022-2027 ($ million)
  • Exhibits36: Chart on Thrombolytics - Year-over-year growth 2022-2027 (%)
  • Exhibits37: Data Table on Thrombolytics - Year-over-year growth 2022-2027 (%)
  • Exhibits38: Chart on Anticoagulants - Market size and forecast 2022-2027 ($ million)
  • Exhibits39: Data Table on Anticoagulants - Market size and forecast 2022-2027 ($ million)
  • Exhibits40: Chart on Anticoagulants - Year-over-year growth 2022-2027 (%)
  • Exhibits41: Data Table on Anticoagulants - Year-over-year growth 2022-2027 (%)
  • Exhibits42: Chart on Antiplatelets - Market size and forecast 2022-2027 ($ million)
  • Exhibits43: Data Table on Antiplatelets - Market size and forecast 2022-2027 ($ million)
  • Exhibits44: Chart on Antiplatelets - Year-over-year growth 2022-2027 (%)
  • Exhibits45: Data Table on Antiplatelets - Year-over-year growth 2022-2027 (%)
  • Exhibits46: Chart on Antihypertensives - Market size and forecast 2022-2027 ($ million)
  • Exhibits47: Data Table on Antihypertensives - Market size and forecast 2022-2027 ($ million)
  • Exhibits48: Chart on Antihypertensives - Year-over-year growth 2022-2027 (%)
  • Exhibits49: Data Table on Antihypertensives - Year-over-year growth 2022-2027 (%)
  • Exhibits50: Chart on Other therapeutics - Market size and forecast 2022-2027 ($ million)
  • Exhibits51: Data Table on Other therapeutics - Market size and forecast 2022-2027 ($ million)
  • Exhibits52: Chart on Other therapeutics - Year-over-year growth 2022-2027 (%)
  • Exhibits53: Data Table on Other therapeutics - Year-over-year growth 2022-2027 (%)
  • Exhibits54: Market opportunity by Type ($ million)
  • Exhibits55: Chart on Distribution Channel - Market share 2022-2027 (%)
  • Exhibits56: Data Table on Distribution Channel - Market share 2022-2027 (%)
  • Exhibits57: Chart on Comparison by Distribution Channel
  • Exhibits58: Data Table on Comparison by Distribution Channel
  • Exhibits59: Chart on Hospital pharmacies - Market size and forecast 2022-2027 ($ million)
  • Exhibits60: Data Table on Hospital pharmacies - Market size and forecast 2022-2027 ($ million)
  • Exhibits61: Chart on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
  • Exhibits62: Data Table on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
  • Exhibits63: Chart on Retail pharmacies - Market size and forecast 2022-2027 ($ million)
  • Exhibits64: Data Table on Retail pharmacies - Market size and forecast 2022-2027 ($ million)
  • Exhibits65: Chart on Retail pharmacies - Year-over-year growth 2022-2027 (%)
  • Exhibits66: Data Table on Retail pharmacies - Year-over-year growth 2022-2027 (%)
  • Exhibits67: Chart on Online pharmacies - Market size and forecast 2022-2027 ($ million)
  • Exhibits68: Data Table on Online pharmacies - Market size and forecast 2022-2027 ($ million)
  • Exhibits69: Chart on Online pharmacies - Year-over-year growth 2022-2027 (%)
  • Exhibits70: Data Table on Online pharmacies - Year-over-year growth 2022-2027 (%)
  • Exhibits71: Market opportunity by Distribution Channel ($ million)
  • Exhibits72: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits73: Chart on Market share By Geographical Landscape 2022-2027 (%)
  • Exhibits74: Data Table on Market share By Geographical Landscape 2022-2027 (%)
  • Exhibits75: Chart on Geographic comparison
  • Exhibits76: Data Table on Geographic comparison
  • Exhibits77: Chart on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibits78: Data Table on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibits79: Chart on North America - Year-over-year growth 2022-2027 (%)
  • Exhibits80: Data Table on North America - Year-over-year growth 2022-2027 (%)
  • Exhibits81: Chart on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibits82: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibits83: Chart on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibits84: Data Table on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibits85: Chart on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibits86: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibits87: Chart on Asia - Year-over-year growth 2022-2027 (%)
  • Exhibits88: Data Table on Asia - Year-over-year growth 2022-2027 (%)
  • Exhibits89: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibits90: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibits91: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • Exhibits92: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • Exhibits93: Chart on US - Market size and forecast 2022-2027 ($ million)
  • Exhibits94: Data Table on US - Market size and forecast 2022-2027 ($ million)
  • Exhibits95: Chart on US - Year-over-year growth 2022-2027 (%)
  • Exhibits96: Data Table on US - Year-over-year growth 2022-2027 (%)
  • Exhibits97: Chart on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibits98: Data Table on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibits99: Chart on UK - Year-over-year growth 2022-2027 (%)
  • Exhibits100: Data Table on UK - Year-over-year growth 2022-2027 (%)
  • Exhibits101: Chart on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibits102: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibits103: Chart on Germany - Year-over-year growth 2022-2027 (%)
  • Exhibits104: Data Table on Germany - Year-over-year growth 2022-2027 (%)
  • Exhibits105: Chart on China - Market size and forecast 2022-2027 ($ million)
  • Exhibits106: Data Table on China - Market size and forecast 2022-2027 ($ million)
  • Exhibits107: Chart on China - Year-over-year growth 2022-2027 (%)
  • Exhibits108: Data Table on China - Year-over-year growth 2022-2027 (%)
  • Exhibits109: Chart on Canada - Market size and forecast 2022-2027 ($ million)
  • Exhibits110: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
  • Exhibits111: Chart on Canada - Year-over-year growth 2022-2027 (%)
  • Exhibits112: Data Table on Canada - Year-over-year growth 2022-2027 (%)
  • Exhibits113: Market opportunity By Geographical Landscape ($ million)
  • Exhibits114: Impact of drivers and challenges in 2022 and 2027
  • Exhibits115: Overview on Criticality of inputs and Factors of differentiation
  • Exhibits116: Overview on factors of disruption
  • Exhibits117: Impact of key risks on business
  • Exhibits118: Vendors covered
  • Exhibits119: Matrix on vendor position and classification
  • Exhibits120: Amgen Inc. - Overview
  • Exhibits121: Amgen Inc. - Product / Service
  • Exhibits122: Amgen Inc. - Key offerings
  • Exhibits123: AstraZeneca Plc - Overview
  • Exhibits124: AstraZeneca Plc - Product / Service
  • Exhibits125: AstraZeneca Plc - Key news
  • Exhibits126: AstraZeneca Plc - Key offerings
  • Exhibits127: Athersys Inc. - Overview
  • Exhibits128: Athersys Inc. - Product / Service
  • Exhibits129: Athersys Inc. - Key offerings
  • Exhibits130: Bayer AG - Overview
  • Exhibits131: Bayer AG - Business segments
  • Exhibits132: Bayer AG - Key offerings
  • Exhibits133: Bayer AG - Segment focus
  • Exhibits134: Biogen Inc. - Overview
  • Exhibits135: Biogen Inc. - Product / Service
  • Exhibits136: Biogen Inc. - Key offerings
  • Exhibits137: Boehringer Ingelheim International GmbH - Overview
  • Exhibits138: Boehringer Ingelheim International GmbH - Business segments
  • Exhibits139: Boehringer Ingelheim International GmbH - Key news
  • Exhibits140: Boehringer Ingelheim International GmbH - Key offerings
  • Exhibits141: Boehringer Ingelheim International GmbH - Segment focus
  • Exhibits142: Bristol Myers Squibb Co. - Overview
  • Exhibits143: Bristol Myers Squibb Co. - Product / Service
  • Exhibits144: Bristol Myers Squibb Co. - Key offerings
  • Exhibits145: Daiichi Sankyo Co. Ltd. - Overview
  • Exhibits146: Daiichi Sankyo Co. Ltd. - Business segments
  • Exhibits147: Daiichi Sankyo Co. Ltd. - Key news
  • Exhibits148: Daiichi Sankyo Co. Ltd. - Key offerings
  • Exhibits149: Daiichi Sankyo Co. Ltd. - Segment focus
  • Exhibits150: F. Hoffmann La Roche Ltd. - Overview
  • Exhibits151: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibits152: F. Hoffmann La Roche Ltd. - Key news
  • Exhibits153: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibits154: F. Hoffmann La Roche Ltd. - Segment focus
  • Exhibits155: Johnson and Johnson - Overview
  • Exhibits156: Johnson and Johnson - Business segments
  • Exhibits157: Johnson and Johnson - Key news
  • Exhibits158: Johnson and Johnson - Key offerings
  • Exhibits159: Johnson and Johnson - Segment focus
  • Exhibits160: Medtronic Plc - Overview
  • Exhibits161: Medtronic Plc - Business segments
  • Exhibits162: Medtronic Plc - Key news
  • Exhibits163: Medtronic Plc - Key offerings
  • Exhibits164: Medtronic Plc - Segment focus
  • Exhibits165: Merck and Co. Inc. - Overview
  • Exhibits166: Merck and Co. Inc. - Business segments
  • Exhibits167: Merck and Co. Inc. - Key news
  • Exhibits168: Merck and Co. Inc. - Key offerings
  • Exhibits169: Merck and Co. Inc. - Segment focus
  • Exhibits170: Pfizer Inc. - Overview
  • Exhibits171: Pfizer Inc. - Product / Service
  • Exhibits172: Pfizer Inc. - Key news
  • Exhibits173: Pfizer Inc. - Key offerings
  • Exhibits174: Sanofi SA - Overview
  • Exhibits175: Sanofi SA - Business segments
  • Exhibits176: Sanofi SA - Key news
  • Exhibits177: Sanofi SA - Key offerings
  • Exhibits178: Sanofi SA - Segment focus
  • Exhibits179: Teva Pharmaceutical Industries Ltd. - Overview
  • Exhibits180: Teva Pharmaceutical Industries Ltd. - Business segments
  • Exhibits181: Teva Pharmaceutical Industries Ltd. - Key news
  • Exhibits182: Teva Pharmaceutical Industries Ltd. - Key offerings
  • Exhibits183: Teva Pharmaceutical Industries Ltd. - Segment focus
  • Exhibits184: Inclusions checklist
  • Exhibits185: Exclusions checklist
  • Exhibits186: Currency conversion rates for US$
  • Exhibits187: Research methodology
  • Exhibits188: Validation techniques employed for market sizing
  • Exhibits189: Information sources
  • Exhibits190: List of abbreviations